STAT3 phosphorylation in central leptin resistance
H Liu, T Du, C Li, G Yang - Nutrition & metabolism, 2021 - Springer
Mechanism exploitation of energy homeostasis is urgently required because of the
worldwide prevailing of obesity-related metabolic disorders in human being. Although it is …
worldwide prevailing of obesity-related metabolic disorders in human being. Although it is …
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Y Hu, Z Dong, K Liu - Journal of Experimental & Clinical Cancer Research, 2024 - Springer
Signal transducer and activator of transcription 3 (STAT3) is a transcriptional factor involved
in almost all cancer hallmark features including tumor proliferation, metastasis …
in almost all cancer hallmark features including tumor proliferation, metastasis …
Pharmacological inhibition of oncogenic STAT3 and STAT5 signaling in hematopoietic cancers
M Brachet-Botineau, M Polomski, HA Neubauer… - Cancers, 2020 - mdpi.com
Signal Transducer and Activator of Transcription (STAT) 3 and 5 are important effectors of
cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated …
cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated …
Transcription factors in cancer: when alternative splicing determines opposite cell fates
S Belluti, G Rigillo, C Imbriano - Cells, 2020 - mdpi.com
Alternative splicing (AS) is a finely regulated mechanism for transcriptome and proteome
diversification in eukaryotic cells. Correct balance between AS isoforms takes part in …
diversification in eukaryotic cells. Correct balance between AS isoforms takes part in …
[HTML][HTML] PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia
Overexpression of phosphatases of regenerating liver 2 (PRL2), detected in numerous
diverse cancers, is often associated with increased severity and poor patient prognosis …
diverse cancers, is often associated with increased severity and poor patient prognosis …
STAT3, the challenge for chemotherapeutic and radiotherapeutic efficacy
PL Yang, LX Liu, EM Li, LY Xu - Cancers, 2020 - mdpi.com
Simple Summary STAT3, an oncogene, contributes to insensitivity of chemotherapy and
radiotherapy in tumor, reduces the clinical efficacy. Meanwhile, STAT3β, a STAT3 splicing …
radiotherapy in tumor, reduces the clinical efficacy. Meanwhile, STAT3β, a STAT3 splicing …
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis
CJ Stavast, I van Zuijen, E Karkoulia, A Özçelik… - Leukemia, 2022 - nature.com
MIR139 is a tumor suppressor and is commonly silenced in acute myeloid leukemia (AML).
However, the tumor-suppressing activities of miR-139 and molecular mechanisms of …
However, the tumor-suppressing activities of miR-139 and molecular mechanisms of …
STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance
A Witalisz-Siepracka, CM Denk, B Zdársky… - Frontiers in …, 2024 - frontiersin.org
Acute myeloid leukemia (AML) is a heterogenous disease characterized by the clonal
expansion of myeloid progenitor cells. Despite recent advancements in the treatment of …
expansion of myeloid progenitor cells. Despite recent advancements in the treatment of …
The ups and downs of STAT inhibition in acute myeloid leukemia
Aberrant Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling
is implicated in the pathogenesis of acute myeloid leukemia (AML), a highly heterogeneous …
is implicated in the pathogenesis of acute myeloid leukemia (AML), a highly heterogeneous …